Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where De-Cai Yu is active.

Publication


Featured researches published by De-Cai Yu.


Oncology Reports | 2015

USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo

Xianwen Yuan; Xitai Sun; Xiaolei Shi; Chunping Jiang; De-Cai Yu; Weiwei Zhang; Wenxian Guan; Jianxin Zhou; Yafu Wu; Yu-Dong Qiu; Yitao Ding

Ubiquitin specific protease 39 (USP39) plays an important role in mRNA splicing. In the present study, we investigated the role of USP39 in regulating the growth of hepatocellular carcinoma (HCC). We detected USP39 expression in more than 100 HCC clinical samples. The USP39 expression was significantly higher in the tumor tissues compared to the adjacent normal tissues, and was strongly associated with the pathological grade of HCC. USP39 knockdown inhibited cell proliferation and colony formation in vitro in the HepG2 cells, while upregulation of USP39 promoted tumor cell growth. FCM assay showed that USP39 knockdown led to G2/M arrest and induced apoptosis in the HepG2 cells. USP39 knockdown by shRNA inhibited xenograft tumor growth in nude mice. Moreover, USP39 knockdown led to the upregulation of p-Cdc2 and downregulation of p-Cdc25c and p-myt1, while the expression of total Cdc2, Cdc25c and myt1 was not changed in the USP39-knockdown cells. We also found that p-Cdc2 was decreased in the USP39-overexpressing cells and was upregulated in the xenografted tumors derived from the HepG2/KD cells from nude mice. Meanwhile, the expression levels of FoxM1 and its target genes PLK1 and cyclin B1 were decreased in the USP39-knockdown cells. These results suggest that USP39 may contribute to FoxM1 splicing in HCC tumor cells. Our data indicate that USP39 knockdown inhibited the growth of HCC both in vitro and in vivo through G2/M arrest, which was partly achieved via the inhibition of FoxM1 splicing.


Journal of Surgical Oncology | 2011

A modified technique for end-to-side pancreaticojejunostomy by purse-string suture.

Chunping Jiang; Meng Wang; Qingxiang Xu; Xing-Yu Wu; De-Cai Yu; Yitao Ding

Pancreatic fistula is a leading cause of morbidity and mortality after pancreaticoduodenectomy. We designed a modified technique, by which the pancreatic stump was invaginated into the jejunal loop by purse‐string suture.


Chinese Journal of Cancer Research | 2014

Dermatosis as the initial presentation of gastric cancer: two cases

Wei Ge; Bu-Wei Teng; De-Cai Yu; Gang Chen; Li-ming Zheng; Yitao Ding

Paraneoplastic dermatoses are known to be certain dermatosis related with tumor. The common paraneoplastic dermatoses are acanthosis nigricans, acquired ichthyosis, dermatomyositis, erythroderma, and so on. Here we report two cases of paraneoplastic dermatoses associated with gastric cancer. One case was a 57-year-old man with dermatomyositis and proved to be associated with gastric cancer through stomachoscopy. The other was a 66-year-old man with erythroderma and proved to be associated with gastric cancer through stomachoscopy. Both cases were treated with radical total gastrectomy with lymphadenectomy (D2) and esophagojejunostomy of Roux-en-Y. The skin symptom of both cases had improved a lot but still existed after operation. Paraneoplastic dermatoses can be seen as the early manifestation of visceral carcinomas. As a result, gastric cancers should be excluded in the patients with paraneoplastic dermatoses.


World Journal of Gastroenterology | 2003

The development of a new bioartificial liver and its application in 12 acute liver failure patients.

Yitao Ding; Yu-Dong Qiu; Zhong Chen; Qingxiang Xu; Heyuan Zhang; Qing Tang; De-Cai Yu


World Journal of Gastroenterology | 2012

Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma

Xitai Sun; Xianwen Yuan; Haitao Zhu; Zhengming Deng; De-Cai Yu; Xiang Zhou; Yitao Ding


Annals of Clinical and Laboratory Science | 2003

Function of a New Internal Bioartificial Liver: An In Vitro Study

Qingxiang Xu; De-Cai Yu; Yu-Dong Qiu; Heyuan Zhang; Yitao Ding


Artificial Organs | 2003

Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model.

Zhong Chen; Yitao Ding; Qingxiang Xu; De-Cai Yu


Hepatobiliary & Pancreatic Diseases International | 2013

Risk assessment in patients undergoing liver resection.

De-Cai Yu; Weibo Chen; Chunping Jiang; Yitao Ding


Hepatobiliary & Pancreatic Diseases International | 2004

A reliable graded acute liver failure model in rats: treatment with internal bioartificial liver.

Xu Qx; Yitao Ding; Qiu Yd; De-Cai Yu; Zhang Hy


International Journal of Clinical and Experimental Pathology | 2015

Radiological score for hemorrhage in the patients with portal hypertension.

Wei Ge; Yi Wang; Yajuan Cao; Min Xie; Yitao Ding; Ming Zhang; De-Cai Yu

Collaboration


Dive into the De-Cai Yu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge